• Our People
  • Global Presence
  • Regions
    • Asia
    • Europe
    • Americas
  • Offices
    • Canada
      • Ottawa
      • Toronto
    • China
      • Beijing
      • Hong Kong
    • France
      • Paris
      • Sophia Antipolis
    • Luxembourg
    • Malaysia
    • Singapore
    • UK
      • Aberdeen
      • Birmingham
      • Cambridge
      • Edinburgh
      • Glasgow
      • London
      • Manchester
      • Oxford
  • Client liaison
    • Japan
    • Korea
  • Expertise
  • Services
    • Patents
    • Brands & Trade Marks
    • Designs
    • Litigation & Dispute Resolution
    • Commercial IP & Contracts
    • Due Diligence
    • Freedom to Operate
    • EPO Patent Oppositions
    • European Patent Validations
    • Anti-counterfeiting
    • Open Source & Third Party Code
  • Sectors
    • Energy & Environment
    • Life Sciences
    • Agritech
    • Medical Technologies
    • Chemistry
    • Transport
    • Entertainment & Creative Industries
    • Food & Drink
    • Fashion & Retail
    • Universities & Research Bodies
    • Start-ups & Spin-outs
    • Digital Transformation
      • 3D Printing
      • Artificial Intelligence
      • Blockchain
      • Data & Connectivity
      • Extended Reality
      • Industry 4.0
  • About Us
    • Working with us
    • Awards
    • Corporate & Social Responsibility
    • Diversity & Inclusion
    • Careers
  • Articles
    • Events
    • M&C Reacts
    • European Trade Mark Hub
    • Unitary Patent & Unified Patent Court
    • All publications
  • Contact Us
Marks & Clerk logo (magenta)
Marks & Clerk logo (magenta)
Contact Us
Language
English Français 中文(简体) 中文(繁體) 한국어 日本語
Our People
Global Presence
Regions
  • Asia
  • Europe
  • Americas
Offices
  • Canada
    • Ottawa
    • Toronto
  • China
    • Beijing
    • Hong Kong
  • France
    • Paris
    • Sophia Antipolis
  • Luxembourg
  • Malaysia
  • Singapore
  • UK
    • Aberdeen
    • Birmingham
    • Cambridge
    • Edinburgh
    • Glasgow
    • London
    • Manchester
    • Oxford
Client liaison
  • Japan
  • Korea
Expertise
Services
  • Patents
  • Brands & Trade Marks
  • Designs
  • Litigation & Dispute Resolution
  • Commercial IP & Contracts
  • Due Diligence
  • Freedom to Operate
  • EPO Patent Oppositions
  • European Patent Validations
  • Anti-counterfeiting
  • Open Source & Third Party Code
Sectors
  • Energy & Environment
  • Life Sciences
  • Agritech
  • Medical Technologies
  • Chemistry
  • Transport
  • Entertainment & Creative Industries
  • Food & Drink
  • Fashion & Retail
  • Universities & Research Bodies
  • Start-ups & Spin-outs
  • Digital Transformation
    • 3D Printing
    • Artificial Intelligence
    • Blockchain
    • Data & Connectivity
    • Extended Reality
    • Industry 4.0
About Us
  • Working with us
  • Awards
  • Corporate & Social Responsibility
  • Diversity & Inclusion
  • Careers
Articles
  • Events
  • M&C Reacts
  • European Trade Mark Hub
  • Unitary Patent & Unified Patent Court
  • All publications

XR Report 2022

Patent trends - analysis & key findings

Read the report

AI Report 2022

Marks & Clerk is the leading firm for patenting artificial intelligence innovations

Read our analysis & key findings

Unitary Patent & Unified Patent Court

Your global resource for the new system for granting and litigating patents in Europe

Find out more
300
practitioners
around the world
Find an expert
135
years
of excellence
Services
17
Offices
across three continents
Locations
1
leading firm
in IP services
About us

For more than a century, Marks & Clerk has been a leading global intellectual property firm.

We provide businesses of all shapes and sizes with people whose legal, commercial and technical expertise exactly meets their needs. Our large team of patent attorneys, trade mark attorneys, commercial lawyers and IP litigators has helped thousands of businesses all over the world protect, enforce and maximise the value of their intellectual property.

Latest Insights

Pills and science flasks photo
Article
- 06 July 2022

Overstated confidence and oversimplified situation: Court rejects obviousness argument in favour of mirabegron patent.

In two actions that were heard together, Teva and Sandoz (‘the Claimants’) sought revocation of Astellas’ patent EP (UK) 1 559 427 B1 (‘the Patent’). The judgment deals with the Claimants’ allegation that the patent is invalid due to obviousness over a piece of cited prior art and insufficiency run as a ‘squeeze’ against obviousness.
Read more
Header image: Laboratory with microscope and test tubes
Article
- 04 July 2022

Court of Appeal dismisses ‘Lay Patient ’ argument agreeing divisional valid (Neurim v Mylan)

This is the end of the hard-fought UK battle between Neurim and Mylan. The Court of Appeal upheld Mr Justice Marcus Smith’s decision that the divisional patent was valid and infringed and so Mylan will now be subjected to a final injunction. The battle will continue in the European Patent Office (EPO), particularly as the parties agreed a cross-undertaking in damages in the event that the EPO revoke the patent (meaning Mylan dropped its application to stay the final injunction pending the EPO decision).
Read more
Article
- 29 June 2022

Damages – no turning back

The winner in an intellectual property infringement action will normally ask the court for an order for procedures to take place so that a proper level of compensation or restitution can be calculated. There are two different ways in which that money can be calculated, namely an inquiry as to damages, and an account of profits.
Read more

Stay informed

IP insights direct to your inbox

Subscribe
Marks & Clerk logo (white)
  • Terms & Conditions
  • Privacy Notice
  • Cookies
  • Legal Notices
  • Lexology
  • Mondaq